Companies: 10,638     total market cap: โ‚ฌ116.167 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Dynavax Technologies
DVAX
#5494
Rank
โ‚ฌ1.09 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
9,33ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-23.19%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for Dynavax Technologies (DVAX)

Revenue in 2025 (TTM): โ‚ฌ0.29 Billion

According to Dynavax Technologies 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.28 Billion. In 2024 the company made a revenue of โ‚ฌ0.26 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dynavax Technologies from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.29 B10.36%
2024 โ‚ฌ0.26 B26.79%
2023 โ‚ฌ0.21 B-68.81%
2022 โ‚ฌ0.67 B73.63%
2021 โ‚ฌ0.38 B925.26%
2020 โ‚ฌ37.84 M20.38%
2019 โ‚ฌ31.43 M338.72%
2018 โ‚ฌ7.16 M2529.45%
2017 โ‚ฌ0.27 M-97.4%
2016 โ‚ฌ10.49 M240.93%
2015 โ‚ฌ3.07 M-55.12%
2014 โ‚ฌ6.86 M-15.79%
2013 โ‚ฌ8.14 M10.94%
2012 โ‚ฌ7.34 M-55.88%
2011 โ‚ฌ16.64 M-7.57%
2010 โ‚ฌ18 M-36.02%
2009 โ‚ฌ28.14 M6.06%
2008 โ‚ฌ26.53 M174.9%
2007 โ‚ฌ9.65 M162.76%
2006 โ‚ฌ3.67 M-70.31%
2005 โ‚ฌ12.37 M13.3%
2004 โ‚ฌ10.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
โ‚ฌ91.57 M-67.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.62 B 2,945.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.06 B 19,334.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.93 B 8,700.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.82 B 17,486.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ36.30 B 12,714.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ53.82 B 18,896.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.38 B 4,975.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ30.83 B 10,783.35%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com